This course has expired. View available courses.
Endocrinology, Medication Management
Case studies in diabetes: Escalating treatment with combination GLP-1RA and insulin
Type 2 diabetes (T2D) is a complex disease that affects many body systems over time. New treatment options and combinations have proven benefits in reducing diabetes-related complications, in addition to their glucose-lowering effects.
GLP-1 receptor agonists (GLP-1RAs) comprise another tool in the GP’s toolbox to optimise glycaemic control while accommodating for comorbidities such as elevated cardiovascular risk and body weight.
New PBS reimbursement criteria mean that co-administration of weekly GLP-1RAs and insulin is now possible, presenting a powerful new treatment combination for complex patients.
This program will give you the skills and knowledge to identify patient groups who may benefit from concomitant use of weekly GLP-1RAs and insulin, and to prescribe GLP-1RAs with safety and efficacy in mind.
This program is supported by an independent educational grant provided from Eli Lilly.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
2
ACCREDITATION
RACGP CPD Program
EXPIRY DATE
2022-08-09
Type 2 diabetes (T2D) is a complex disease that affects many body systems over time. New treatment options and combinations have proven benefits in reducing diabetes-related complications, in addition to their glucose-lowering effects.
GLP-1 receptor agonists (GLP-1RAs) comprise another tool in the GP’s toolbox to optimise glycaemic control while accommodating for comorbidities such as elevated cardiovascular risk and body weight.
New PBS reimbursement criteria mean that co-administration of weekly GLP-1RAs and insulin is now possible, presenting a powerful new treatment combination for complex patients.
This program will give you the skills and knowledge to identify patient groups who may benefit from concomitant use of weekly GLP-1RAs and insulin, and to prescribe GLP-1RAs with safety and efficacy in mind.
This program is supported by an independent educational grant provided from Eli Lilly.
Faculty
Dr Anita Sharma, General Practitioner, Queensland.
Dr Ted Wu, Director of the Diabetes Centre, Royal Prince Alfred Hospital.
Prof Richard MacIsaac, Professor and Director of Endocrinology & Diabetes, St. Vincent’s Health.
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Recognise the clinical benefits of GLP1-RAs in treatment of type 2 diabetes (T2D) when combined with insulin therapy
- Identify patient groups likely to benefit from concomitant use of insulin and GLP-1RAs
- Appreciate the potential impact of new Pharmaceutical Benefits Scheme (PBS) reimbursements on the use of weekly GLP-1RAs in clinical practice
- Recognise the role of the GP in optimising T2D outcomes through regular review and treatment escalation as appropriate
Accreditation
This Active Learning Module has been approved by RACGP CPD Program for 2 CPD points.
Activity no. 284625
Members are able to claim CPD activity points for 2 points through 'Quick log' on their RACGP CPD Dashboard.
# of credits: 2
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
